Antimicrobial Resistance and Antimicrobial Activity of Bioactive Compounds in Drug Formulations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 301
Special Issue Editors
Interests: pathogenic bacteria; food-borne zoonozes; virulence factors; bacteria–host relationships; infectious immunology; molecular biology; ecology of pathogens; new antibacterial agents; antimicrobial resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) to clinically approved antibiotics and chemotherapeutics in human and veterinary medicine has been a global challenge for over 60 years. It has been reported that deaths caused by AMR could increase from 700,000 in 2014 to 10 million by 2050.
Most antibiotics and chemotherapeutics actively damage cells, and therefore, they cannot completely destroy bacterial cells in biofilms. Biofilm formation is associated with the adhesion, motility, resistance to antibiotics, DNA transfer, autolysis, metabolic activity, etc., abilities of bacteria. These factors are regulated by the expression of genes united in a system called quorum sensing. Inhibitors of this system, respective of gene expression, can be bioactive molecules that do not affect bacterial growth or mimic the action of signaling molecules. This is why the search for and identification of new biologically active molecules of which the action is enhanced by their inclusion in drug formulations are of public health importance. Such carriers can be solid lipid nanoparticles, nanocapsules, liposomes, microemulsion drug delivery systems, etc.
This Special Issue aims to introduce new natural compounds with microbiological activities to conventional delivery systems for the prevention and treatment of infectious diseases in human and veterinary medicine. In this Special Issue, original research articles and reviews are welcome. Research areas may include the isolation of bioactive compounds and their loading into drug delivery systems; evaluation of their antimicrobial in vitro or/and in vivo activity, according to the Ethics and Animal Care Committee; their role in quorum sensing system; and determining their stability for practical use.
I look forward to receiving your contributions.
Prof. Dr. Hristo Najdenski
Dr. Lyudmila Dimitrova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new biologically active agents
- drug delivery systems
- antibiotic resistance
- gene expression
- biofilms
- quorum sensing
- in vitro and in vivo models
